The US Food and Drug Administration (FDA) has granted breakthrough device designation to BiVACOR’s titanium Total Artificial Heart (TAH), as a potential bridge to transplant for the adult ...

Artificial heart developer Carmat says it faces financial insolvency by the end of the month.

Duke doctors said Harbison is the second person in the world to receive a BiVACOR heart. Based on the manufacturer's illustrations and Schroder's description, the BiVACOR artificial heart device pumps ...

SNS Insider Projects Explosive Growth in the U.S. Microservices in Healthcare Market—Valued at USD 114.75 Million in 2023—Fueled by HIPAA-Compliant Cloud Platforms, Modular EHR Integration, and ...